Back to Agenda
Panel Discussion
Session Chair(s)
Kazuhiko Ishida, MSC, RPH
Director, Pharmacovigilance, Astellas Pharma Inc., Japan
Hiroki Nagahama, MS
Director, Japan Safety Risk Management Lead, Clinical Safety & Pharmacovigilance, GlaxoSmithKline K.K., Japan
Speaker(s)
Toyotaka Iguchi, MD, PHD
Director, Office of Safety II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Masahiro Ohba
, Isehara Kyodo Hospotal, Japan
Hideo Nakada, RPH
Deputy Associate Manager, Department of Hospital Pharmacy, Keio University, Japan
Kazuhiro Keitoku
Director, Head of Global Patient Safety, Japan, Beone Medicines Japan, Japan
Naoto Oiri
, Chugai Pharmaceutical Co., Ltd., Japan
Emiko Iida, MPHARM
, Daiichi Sankyo Co Ltd, Japan
Have an account?